Prior Acts Coverage

Prior Acts Coverage, also known as Retroactive Coverage, is an insurance policy provision that covers incidents or claims that occurred before the policy's effective date, but were discovered or filed during the policy period. This coverage is particularly relevant for claims-made policies, which only provide coverage for claims that are made during the policy period, as opposed to occurrence-based policies, which provide coverage for incidents that occurred during the policy period regardless of when the claim is made.

For example, if a professional liability insurance policy is purchased in 2023, but the insured party is sued for an incident that occurred in 2021, the policy with prior acts coverage would cover the claim, whereas a policy without this coverage would not.

Key features of Prior Acts Coverage include:

• Coverage for claims made during the policy period for incidents that occurred before the policy's effective date

• Applicable to claims-made policies, which only provide coverage for claims made during the policy period

• Helps protect the insured party from uncovered claims that were unknown or undiscovered at the time the policy was purchased

• Typically subject to a retroactive date, which is the earliest date that coverage will apply for incidents that occurred before the policy's effective date

• May have additional premium costs associated with the extended coverage.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.